Based on the current observations we suggest that the reduction in TNF-α+γδT cells, TNF-α+γ9+δT cells and IL17+CD4-CD8-γδT cells might be directly linked to the pathogenesis and progression of SLE, and response to therapy. This evidence concerns the gene CD4 and systemic lupus erythematosus.